thioctic acid has been researched along with levodopa in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikota, N; Matsushima, Y; Nakagawa, H; Ozawa, T; Sumiki, E | 1 |
| Cantalamessa, F; Cocco, A; Costa, M; Di Stefano, A; Iannitelli, A; Nasuti, C; Pecci, L; Pinnen, F; Santucci, E; Sozio, P | 1 |
| D'Aurizio, E; Di Stefano, A; Hennink, WE; Siepmann, F; Siepmann, J; Sozio, P; van Nostrum, CF; van Steenbergen, MJ | 1 |
| Gao, B; Guo, L; Liu, Z; Ye, N; Zhang, A; Zhang, H; Zhen, X; Zheng, L; Zhou, S | 1 |
| Abdin, AA; Sarhan, NI | 1 |
| Brunetti, L; Cerasa, LS; Chiavaroli, A; D'Aurizio, E; Di Stefano, A; Hennink, WE; Kok, RJ; Orlando, G; Sozio, P; Vacca, M | 1 |
| Olas, B | 1 |
| Cacciatore, I; Cortesi, R; Di Stefano, A; Drechsler, M; Esposito, E; Pavoni, G; Sguizzato, M | 1 |
| Lin, JY; Liu, ZG; Wang, MH; Wang, XJ; Xie, CL; Zhang, SF | 1 |
| Alqahtani, MJ; Alsharif, I; Anwar, F; Fatima, S; Ismail, T; Karim, A; Khan, H; Khayat, RO; Obaidullah, AJ; Saleem, U; Shah, MA; Vargas-De-La-Cruz, C | 1 |
1 review(s) available for thioctic acid and levodopa
| Article | Year |
|---|---|
Medical Functions of Hydrogen Sulfide.
Topics: Angiogenesis Inducing Agents; Cardiovascular Agents; Cysteine; Diclofenac; Disulfides; Heart; Humans; Hydrogen Sulfide; Kidney; Levodopa; Prostaglandins F, Synthetic; Reperfusion Injury; Sulfides; Thioctic Acid; Thiones; Vasodilator Agents | 2016 |
9 other study(ies) available for thioctic acid and levodopa
| Article | Year |
|---|---|
Endogenous and new synthetic antioxidants for peroxynitrite: selective inhibitory effect of 5-methoxytryptamine and lipoic acid on tyrosine nitration by peroxynitrite.
Topics: 5-Methoxytryptamine; Antioxidants; Chromatography, High Pressure Liquid; Dopamine Agents; Levodopa; Nitrates; Oxidants; Oxidation-Reduction; Proline; Pyrrolidines; Thioctic Acid; Tyrosine | 1999 |
L-dopa- and dopamine-(R)-alpha-lipoic acid conjugates as multifunctional codrugs with antioxidant properties.
Topics: Animals; Antioxidants; Biomarkers; Dopamine; Dopamine Agonists; Drug Stability; Free Radical Scavengers; Glutathione Peroxidase; Humans; Hydrogen-Ion Concentration; Hydrolysis; In Vitro Techniques; Iron Chelating Agents; Kinetics; Levodopa; Male; Motor Activity; Oxidative Stress; Rats; Rats, Wistar; Solubility; Stereoisomerism; Structure-Activity Relationship; Superoxide Dismutase; Thioctic Acid | 2006 |
Preparation and characterization of poly(lactic-co-glycolic acid) microspheres loaded with a labile antiparkinson prodrug.
Topics: Antiparkinson Agents; Delayed-Action Preparations; Diffusion; Drug Carriers; Drug Stability; Emulsions; Half-Life; Lactic Acid; Levodopa; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prodrugs; Solvents; Thioctic Acid | 2011 |
Identification of N-propylnoraporphin-11-yl 5-(1,2-dithiolan-3-yl)pentanoate as a new anti-Parkinson's agent possessing a dopamine D2 and serotonin 5-HT1A dual-agonist profile.
Topics: Animals; Antiparkinson Agents; Aporphines; Binding, Competitive; CHO Cells; Corpus Striatum; Cricetinae; Cricetulus; Dyskinesia, Drug-Induced; HEK293 Cells; Humans; Levodopa; Oxidopamine; Parkinson Disease; Proto-Oncogene Proteins c-fos; Radioligand Assay; Rats; Receptors, Adrenergic; Receptors, Dopamine D2; Serotonin 5-HT1 Receptor Agonists; Stereoisomerism; Structure-Activity Relationship; Thioctic Acid | 2011 |
Intervention of mitochondrial dysfunction-oxidative stress-dependent apoptosis as a possible neuroprotective mechanism of α-lipoic acid against rotenone-induced parkinsonism and L-dopa toxicity.
Topics: Animals; Antiparkinson Agents; Apoptosis; Disease Models, Animal; Levodopa; Mitochondria; Neurons; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Rats; Rotenone; Thioctic Acid; Uncoupling Agents | 2011 |
Biodegradable microspheres loaded with an anti-Parkinson prodrug: an in vivo pharmacokinetic study.
Topics: Absorbable Implants; Animals; Antiparkinson Agents; Delayed-Action Preparations; Lactic Acid; Levodopa; Male; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prodrugs; Rats; Rats, Wistar; Thioctic Acid | 2011 |
L-dopa co-drugs in nanostructured lipid carriers: A comparative study.
Topics: Caffeic Acids; Drug Carriers; Drug Liberation; Half-Life; Humans; Kinetics; Levodopa; Lipids; Microscopy, Electron, Transmission; Nanostructures; Parkinson Disease; Thioctic Acid | 2017 |
Lipoic acid alleviates L‑DOPA‑induced dyskinesia in 6‑OHDA parkinsonian rats via anti‑oxidative stress.
Topics: Animals; Antioxidants; Caspase 3; Disease Models, Animal; Dopaminergic Neurons; Dyskinesia, Drug-Induced; Female; Levodopa; Oxidative Stress; Parkinson Disease; Poly(ADP-ribose) Polymerases; Rats; Reactive Oxygen Species; Substantia Nigra; Thioctic Acid | 2018 |
Administration of α-lipoic acid and silymarin attenuates aggression by modulating endocrine, oxidative stress and inflammatory pathways in mice.
Topics: Aggression; Animals; Antioxidants; Biomarkers; Glutathione; Levodopa; Male; Mice; Nitrites; Oxidative Stress; Silymarin; Testosterone; Thioctic Acid | 2023 |